Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Levetiracetam shows promise as adjunctive therapy for partial onset seizures

Aug. 4, 2000

Anticonvulsants found to lower efficacy of leukemia chemotherapy

Aug. 4, 2000

D-Pharm's DP-b99 successfully completes phase I study as treatment of acute stroke

Aug. 4, 2000

New compounds interacting with 5-HT1A receptors useful for depression, etc.

Aug. 3, 2000

New selective dopamine D4 receptor antagonists useful for psychosis and schizophrenia

Aug. 3, 2000

Concerta approved by FDA, licensed worldwide by Alza

Aug. 3, 2000

Acadia granted phase I SBIR award for neuropsychiatric research

Aug. 3, 2000

Inconclusive results obtained with desferrioxamine in multiple sclerosis trial

Aug. 3, 2000

Possible connection between intestinal bacteria and autism revealed

Aug. 3, 2000

5-HT1A receptor ligands and their use in CNS disorders

Aug. 2, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
CC-3 antibody shows antitumoral activity in penile cancer
BioWorld Science
Advanced penile cancer (PeCa) is a rare cancer affecting the genitourinary tract with a 5-year survival rate of about 10% when metastatic. First-line therapies...